Betulinic acid in complex with a gamma-cyclodextrin derivative decreases proliferation and in vivo tumor development of non-metastatic and metastatic B164A5 cells

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 8235-8255

  Soica, Codruta ^a   Danciu, Corina ^a   Savoiu Balint, Germaine ^a   Borcan, Florin ^a   Ambrus, Rita ^b   Zupko, Istvan ^b   Bojin, Florina ^a   Coricovac, Dorina ^a   Ciurlea, Sorina ^a   Avram, Stefana ^a   Dehelean, Cristina Adriana ^a   Olariu, Teodora ^c   Matusz, Petru ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF SZEGED   (Hungary)

^c VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

Author keywords

Betulinic acid; C57BL 6J mice; DSC; MTT test; SEM; X ray diffraction

Indexed keywords

BETULIC ACID; GAMMA CYCLODEXTRIN DERIVATIVE; OCTAKIS [6 DEOXY 6 (2 SULFANYL ETHANESULFONIC ACID)] GAMMA CYCLODEXTRIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; GAMMA-CYCLODEXTRIN; TRITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; ERYTHEMA; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SKIN; SURVIVAL RATE; TUMOR VOLUME; X RAY DIFFRACTION; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; MELANOMA; PATHOLOGY; SOLUBILITY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG CARRIERS; FEMALE; GAMMA-CYCLODEXTRINS; MELANOMA; MICE; MICE, INBRED C57BL; SOLUBILITY; TRITERPENES; X-RAY DIFFRACTION;

EID: 84900008414     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15058235     Document Type: Article

References (51)

1. Pisha, E.; Chai, H.; Lee, I.-S.; Chagwedera, T.E.; Farnsworth, N.R.; Cordell, G.A.; Beecher, C.W.W.; Fong, H.H.S.; Douglas Kinghorn, A.; Brown, D.M. et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1995, 1, 1046-1051.
2. Mullauer, F.B.; Kessler, J.H.; Medema, J.P. Betulinic acid, a natural compound with potent anticancer effects. Anticancer Drugs 2010, 21, 215-227.
3. Şoica, C.; Peev, C.; Dehelean, C.; Aluas, M.; Zupko, I.; Kasa, P.; Alexa, E. Physico-chemical comparison study of betulinic acid, betulin and birch bark extract and in vitro investigation of their cytotoxic effects towards skin epidermoid carcinoma (A431), breast carcinoma (MCF7) and cervix adenocarcinoma (HeLa) cell-lines. Nat. Prod. Res. 2012, 26, 968-974.
4. Zuco, V.; Supino, R.; Righetti, S.C.; Cleris, L.; Marchesi, E.; Gambacorti-Passerini, C.; Formelli, F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 2002, 175, 17-25.
5. Drag, M.; Surowiak, P.; Drag-Zalesinska, M.; Dietel, M.; Lage, H.; Oleksyszyn, J. Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines. Molecules 2009, 14, 1639-1651.
6. Rieber, M.; Strasberg Rieber, M. Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma. DNA Cell Biol. 1998, 17, 399-406.
7. Sawada, N.; Kataoka, K.; Kondo, K.; Arimochi, H.; Fujino, H.; Takahashi, Y.; Miyoshi, T.; Kuwahara, T.; Monden, Y.; Ohnishi, Y. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. Br. J. Cancer 2004, 90, 1672-1678.
8. Cichewicz, R.H.; Kouzi, S.A. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med. Res. Rev. 2004, 24, 90-114.
9. Şoica, C.M.; Peev, C.I.; Ciurlea, S.; Ambrus, R.; Dehelean, C. Physico-chemical and toxicological evaluations of betulin and betulinic acid interactions with hydrophilic cyclodextrins. Farmacia 2010, 58, 611-619.
10. Dehelean, C.A.; Soica, C.; Peev, C.; Ciurlea, S.; Feflea, S.; Kasa, P., Jr. A pharmaco-toxicological evaluation for betulinic acid mixed with hydroxipropilgamma cyclodextrin on in vitro and in vivo models. Farmacia 2011, 59, 51-59.
11. Dehelean, C.; Şoica, C.; Peev, C.; Gruia, A.T.; Şeclaman, E. Physico-chemical and molecular analysis of antitumoral pentacyclic triterpenes in complexation with gamma-cyclodextrin. Rev. Chim. 2008, 59, 887-890.
12. Şoica, C.; Dehelean, C.; Peev, C.; Coneac, G.; Gruia, A.T. Complexation with hydroxipropil γ cyclodextrin of some pentacyclic triterpenes. Characterisation of their binary products. Farmacia 2008, 56, 182-190.
13. Iyer, A.K.; He, J.; Amiji, M.M. Image-guided nanosystems for targeted delivery in cancer therapy. Curr. Med. Chem. 2012, 19, 3230-3240.
14. Wang, H.M.; Soica, C.; Wenz, G. A comparison investigation on the solubilization of betulin and betulinic acid in cyclodextrin derivatives. Nat. Prod. Commun. 2012, 7, 289-291.
15. Yamamura, S.; Momose, Y. Quantitative analysis of crystalline pharmaceuticals in powders and tablets by a pattern-fitting procedure using X-ray powder diffraction data. Int. J. Pharm. 2001, 212, 203-212.
16. Dehelean, C.A.; Feflea, S.; Molnár, J.; Zupko, I.; Soica, C. Betulin as an antitumor agent tested in vitro on A431, HeLa and MCF7, and as an angiogenic inhibitor in vivo in the CAM assay. Nat. Prod. Commun. 2012, 7, 981-985.
17. Li, Y.; He, K.; Huang, Y.; Zheng, D.; Gao, C.; Cui, L.; Jin Y.H. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells. Mol. Carcinog. 2010, 49, 630-640.
18. Rzeski, W.; Stepulak, A.; Szymański, M.; Juszczak, M.; Grabarska, A.; Sifringer, M.; Kaczor, J.; Kandefer-Szerszeń, M. Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro. Basic Clin. Pharmacol. Toxicol. 2009, 105, 425-432.
19. Eiznhamer, D.A.; Xu, Z.-Q. Betulinic acid: A promising anticancer candidate. IDrugs 2004, 7, 359-373.
20. Fulda, S.; Debatin, K.-M. Sensitization for anticancer drug-induced apoptosis by betulinic acid. Neoplasia 2005, 7, 162-170.
21. Sami, A.; Taru, M.; Salme, K.; Jari, Y-K. Pharmacological properties of the ubiquitous natural product betulin. Eur. J. Pharm. Sci. 2006, 29, 1-13.
22. Mendonca, E.A.; Lira, M.C.; Rabello, M.M.; Cavalcanti, I.M.; Galdino, S.L.; Pitta, I.R.; Lima Mdo, C.; Pitta, M.G.; Hernandes, M.Z.; Santos-Magalhães, N.S. Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes. AAPS PharmSciTech 2012, 13, 1355-1366.
23. Pourgholami, M.H.; Wangoo, K.T.; Morris, D.L. Albendazole-cyclodextrin complex: Enhanced cytotoxicity in ovarian cancer cells. Anticancer Res. 2008, 28, 2775-2779.
24. Liu, Y.; Chen, G.S.; Chen, Y.; Cao, D.X.; Ge, Z.Q.; Yuan, Y.J. Inclusion complexes of paclitaxel and oligo(ethylenediamino) bridged bis(b-cyclodextrin)s: Solubilization and antitumor activity. Bioorg. Med. Chem. 2004, 12, 5767-5775.
25. Rieber, M.; Rieber Strasberg, M. Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status. Int. J. Cancer 2006, 118, 1135-1143.
26. Cheng, Y.Q.; Chen, Y.; Wu, Q.L.; Fang, J.; Yang, L.J. Effect of betulinic acid on inducing apoptosis of human multiple myeloma cell line RPMI-8226. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009, 17, 1224-1229.
27. Chen, Z.; Wu, Q.; Chen, Y.; He, J. Effects of betulinic acid on proliferation and apoptosis in Jurkat cells and its in vitro mechanism. J. Hua Zhong Univ. Sci. Technol. Med. Sci. 2008, 28, 634-638.
28. Vadivelu, R.K.; Yeap, S.K.; Ali, A.M.; Hamid, M.; Alitheen, N.B. Betulinic acid inhibits growth of cultured vascular smooth muscle cells arrest and apoptosis. Evid-Based Complement. Altern. Med. 2012, 2012, 251362.
29. Fulda, S.; Kroemer, G. Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov. Today 2009, 14, 885-890.
30. Santos, R.C.; Salvador, J.A.R.; Cortés, R.; Pachón, G.; Marín, S.; Cascante, M. New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase dependent apoptosis in human cancer cells. Biochimie 2011, 93, 1065-1075.
31. Zaritskaya, L.; Shurin, M.R.; Sayers, T.J.; Malyguine, A.M. New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev. Vaccines 2010, 9, 601-616.
32. Mullauer, F.B.; Kessler, J.H.; Medema, J.P. Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion. Apoptosis 2009, 14, 191-202.
33. Fulda, S.; Debatin, K.M. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med. Pediatr. Oncol. 2000, 35, 616-618.
34. Liu, W-K.; Ho, J.C.K.; Cheung, F.W.K.; Liu, B.P.L.; Ye, W-C.; Che, C-T. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Eur. J. Pharmacol. 2004, 498, 71-78.
35. Serradell, M.; Díaz-Ricart, M.; Cases, A.; Petriz, J.; Ordinas, A.; Escolar, G. Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture. Nephrol. Dial. Transplant. 2003, 18, 1079-1085.
36. Rubio, N.; Torres, C. Interferon-γ induces proliferation but not apoptosis in murine astrocytes through the differential expression of the myc proto-oncogene family. Mol. Brain Res. 1999, 71, 104-110.
37. Harmand, P.O.; Duval, R.; Delage, C.; Simon, A. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int. J. Cancer 2005, 114, 1-11.
38. Danciu, C.; Borcan, F.; Bojin, F.; Zupko, I.; Dehelean, C. Effect of the isoflavone genistein on tumor size, metastasis potential and melanization in a B16 mouse model of murine melanoma. Nat. Prod. Commun. 2013, 8, 343-346.
39. Cinta Pinzaru, S.; Falamas, A.; Dehelean, C.A. Molecular conformation changes along the malignancy revealed by optical nanosensors. J. Cell. Mol. Med. 2013, 17, 277-286.
40. Dehelean, C.A.; Feflea, S.; Ganta, S.; Amiji, M.M. Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay. J. Biomed. Nanotechnol. 2011, 7, 317-324.
41. Galgon, T.; Wohlrab, W.; Dräger, B. Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes. Exp. Dermatol. 2005, 14, 736-743.
42. Ciurlea, S.A.; Dehelean, C.A.; Ionescu, D.; Berko, S.; Csanyi, E.; Hadaruga, D.I.; Ganta, S.; Amiji, M.M. A comparative study regarding melanoma activity of betulinic acid on topical ointment vs. systemic nanoemulsion delivery systems. J. Agroaliment. Process. Technol. 2010, 16, 420-426.
43. Fulda, S. Betulinic acid for cancer treatment and prevention. Int. J. Mol. Sci. 2008, 9, 1096-1107.
44. Yogeeswari, P.; Sriram, D. Betulinic acid and its derivatives: A review on their biological properties. Curr. Med. Chem. 2005, 12, 657-666.
45. Mertens-Talcott, S.U.; Noratto, G.D.; Li, X.; Angel-Morales, G.; Bertoldi, M.C.; Safe, S. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of Sp transcription factors and microRNA-27a: ZBTB10. Mol. Carcinog. 2013, 52, 591-602.
46. Şoica, C.; Dehelean, C.; Danciu, C.; Wang, H.M.; Wenz, G.; Ambrus, R.; Bojin, F.; Anghel, M. Betulin complex in γ-cyclodextrin derivatives: Properties and antineoplasic activities in vitro and in vivo tumor models. Int. J. Mol. Sci. 2012, 13, 14992-15011.
47. Xu, W.; Ling, P.; Zhang, T. Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J. Drug Deliv. 2013, 2013, 340315.
48. Lee, S.C.; Huh, K.M.; Lee, J.; Cho, Y.W.; Galinsky, R.E.; Park, K. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: In vitro and in vivo characterization. Biomacromolecules 2007, 8, 202-208.
49. Awasthi, N.; Zhang, C.; Schwarz, A.M.; Hinz, S.; Wang, C.; Williams, N.S.; Schwarz, M.A.; Schwarz, R.E. Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer. Carcinogenesis 2013, 34, 2361-2369.
50. Giavazzi, R.; Campbell, D.E.; Jessup, J.M.; Cleary, K.; Fidler, I.J. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res. 1986, 46, 1928-1933.
51. Hoshino, T.; Matsuda, M.; Yamashita, Y.; Takehara, M.; Fukuya, M.; Mineda, K.; Maji, D.; Ihn, H.; Adachi, H.; Sobue, G. et al. Suppression of melanin production by expression of hsp70. J. Biol. Chem. 2010, 285, 13254-13263.